Want to see VRTX full AI Analyst Report?
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Report
VRTX Q1 2024 EPS Results
- Actual EPS
- $4.76
- Consensus EPS
- $4.07
- Beat/Miss
- Beat by +$0.69
- One Year Ago EPS
- $3.05
VRTX Q1 2024 Revenue Results
- Actual Revenue
- $2.69B
- Expected Revenue
- $2.58B
- Beat/Miss
- Beat by +$105.95M
- YoY Revenue Growth
- +14.21%
Earnings Announcement Details
- Quarter
- Q1 2024
- Date
- 05/06/2024
- Time
- After Close
- Conference Call
- Monday, May 6, 2024
Q1 2024 Earnings Call Audio
VRTX Q1 2024 Earnings Call
0:00 / 0:00
Q1 2024 Earnings Slide Deck
Q1 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
VRTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 02, 2026 | 2026 (Q3) | 4.82- | 4.8 | ― | |
| Aug 03, 2026 | 2026 (Q2) | 4.744.73 | 4.52 | 4.65% (+0.21) | |
| May 04, 2026 | 2026 (Q1) | 4.244.47 | 4.06 | 10.10% (+0.41) | |
| Feb 12, 2026 | 2025 (Q4) | 5.115.03 | 3.98 | 26.38% (+1.05) | |
| Nov 03, 2025 | 2025 (Q3) | 4.574.80 | 4.38 | 9.59% (+0.42) | |
| Aug 06, 2025 | 2025 (Q2) | 4.294.52 | -12.83 | 135.23% (+17.35) | |
| May 05, 2025 | 2025 (Q1) | 4.324.06 | 4.76 | -14.71% (-0.70) | |
| Feb 10, 2025 | 2024 (Q4) | 4.023.98 | 4.2 | -5.24% (-0.22) | |
| Nov 04, 2024 | 2024 (Q3) | 4.084.38 | 4.08 | 7.35% (+0.30) | |
| Aug 01, 2024 | 2024 (Q2) | -11.63-12.83 | 3.89 | -429.82% (-16.72) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed